Skip to main content
Year archive

SOMNOMED LIMITED — 2019 filings

All 28 regulatory filings released by SOMNOMED LIMITED (SOM) in 2019, sourced directly from the official regulator.

28 Filings
2019 Period
2019 filings (28)
Filing Released Lang
AGM addresses to Shareholders 5 pages 389.2KB
AGM Information
2019-11-20 English
Results of Meeting 2 pages 143.0KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-20 English
SomnoMed Limited signs agreement with App-Nea LLC 1
Capital/Financing Update
2019-10-29 English
Strong North American revenue growth in Q1 2 pages 198.8KB
Earnings Release Q1 2020
2019-10-27 English
Appendix 4C - quarterly 6 pages 323.3KB
Interim / Quarterly Report Q1 2020
2019-10-27 English
Notice of Annual General Meeting 3 pages 207.6KB
AGM Information
2019-10-08 English
Proxy Form 2 pages 151.5KB
Proxy Solicitation & Information Statement
2019-10-08 English
Annual Report to shareholders 70 pages 1.7MB
Annual Report FY 2019
2019-09-22 English
Corporate Governance Statement & Appendix 4G 27 pages 280.9KB
Governance Information
2019-09-22 English
Appointment Sales & Marketing Exec. VP North America 1
Board/Management Information
2019-09-16 English
Change of Director's Interest Notice 2 pages 285.9KB
Director's Dealing
2019-09-02 English
Appendix 3B - Lapse of options 12 pages 531.3KB
Share Issue/Capital Change
2019-09-02 English
Preliminary Final Report 36 pages 452.4KB
Annual Report FY 2019
2019-08-20 English
Investor Presentation 27 pages 1.4MB
Investor Presentation
2019-08-20 English
Full year results - Investor Conference Call & Webcast 1
Report Publication Announcement
2019-08-12 English
North American direct revenues up 31% in Q4 2 pages 363.3KB
Interim / Quarterly Report Q4 2019
2019-07-22 English
Appendix 4C - quarterly 6 pages 243.8KB
Interim / Quarterly Report Q4 2019
2019-07-22 English
500,000 patients treated worldwide 1 page 335.3KB
Regulatory Filings
2019-07-07 English
Becoming a substantial holder 3 pages 188.5KB
Major Shareholding Notification
2019-05-22 English
SomnoDent Avant receives FDA clearance 1 page 431.4
Regulatory Filings
2019-05-12 English
Core revenue growth up 9% in Q3 1 page 263.0KB
Earnings Release Q3 2019
2019-04-28 English
Appendix 4C - quarterly 6 pages 210.2KB
Interim / Quarterly Report Q3 2019
2019-04-28 English
Appointment of Chief Financial Officer 1 page 320.4
Board/Management Information
2019-04-07 English
Trading update 1 page 353.5KB
Capital/Financing Update
2019-03-24 English
Half Yearly Report and Accounts 20 pages 923.6KB
Interim / Quarterly Report H1 2019
2019-02-20 English
Investor Presentation 19 pages 1.4MB
Investor Presentation
2019-02-20 English
Appendix 4C - quarterly 6 pages 674.5KB
Interim / Quarterly Report Q2 2018
2019-01-28 English
Core revenue growth up 13% in Q2 2 pages 537.0KB
Earnings Release Q2 2019
2019-01-28 English